Form 4 for CRL Charles River Laboratories
Accepted 2024-11-12 00:00:00 ET · period of report 2024-11-06 · accession 0001127602-24-027032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| I | 2024-11-12 | 2024-11-07 | CRL | WALLMAN RICHARD F | Dir | S - Sale | $216.50 | -1,000 | 0 | -100% | -$216.5K |
| M | 2024-11-12 | 2024-11-07 | CRL | WALLMAN RICHARD F | Dir | S - Sale | $216.12 | -6,621 | 15.6K | -30% | -$1.43M |
| 2024-11-12 | 2024-11-06 | CRL | WALLMAN RICHARD F | Dir | G - Gift | $0.00 | -4,540 | 19.0K | -19% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-07 | S | D | 1,000 | $216.50 | 0 | I | — | — | |
| 2 | Common | Common Stock | 2024-11-07 | S | D | 3,250 | $216.50 | 12,386 | D | — | — | |
| 3 | Common | Common Stock | 2024-11-07 | S | D | 3,371 | $215.75 | 15,636 | D | — | — | |
| 4 | Common | Common Stock | 2024-11-06 | G | D | 4,540 | $0.00 | 19,007 | D By Wife | — | — |